Foust, Kevin D.
The Ohio State University,
United States
2025 Rank: 263765
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 1312 out of 66225 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 263765 | 299550 |
| Total Cites | 767 | 815 |
| H-index | 13 | 13 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 121 | 123 |
| Number of Single+First+Last Authored Papers | 16 | 16 |
| Total Cites to Single+First+Last Authored Papers | 161 | 163 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 608 | 636 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.28 |
| Self-Citation Percentage |
5.89%
|
|
Foust, Kevin D.
The Ohio State University,
United States
2024 Rank: 238252
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 1213 out of 62673 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 238252 | 270484 |
| Total Cites | 696 | 752 |
| H-index | 12 | 12 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 122 | 124 |
| Number of Single+First+Last Authored Papers | 16 | 16 |
| Total Cites to Single+First+Last Authored Papers | 166 | 170 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 544 | 571 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.32 |
| Self-Citation Percentage |
7.45%
|
|
Foust, Kevin D.
The Ohio State University,
United States
2023 Rank: 186007
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 918 out of 59267 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 186007 | 202937 |
| Total Cites | 798 | 857 |
| H-index | 14 | 15 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 139 | 143 |
| Number of Single+First+Last Authored Papers | 16 | 16 |
| Total Cites to Single+First+Last Authored Papers | 181 | 190 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 610 | 642 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.33 |
| Self-Citation Percentage |
6.88%
|
|
Foust, Kevin D.
Novartis Gene Therapies,
United States
2022 Rank: 181457
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 858 out of 56174 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 181457 | 206919 |
| Total Cites | 819 | 902 |
| H-index | 13 | 13 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 8 | 8 |
| Total Cites to Single+First Authored Papers | 154 | 159 |
| Number of Single+First+Last Authored Papers | 15 | 15 |
| Total Cites to Single+First+Last Authored Papers | 171 | 177 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 619 | 649 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.39 |
| Self-Citation Percentage |
9.20%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.